Pfizer Inc. (PFE.BA)
-Buenos Aires | Prev Close: | 133.65 |
|---|
| Open: | 133.25 |
|---|
| Bid: | 121.00 |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | N/A |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 133.25 - 133.65 |
|---|
| 52wk Range: | 27.00 - 135.80 |
|---|
| Volume: | 1,092 |
|---|
| Avg Vol (3m): | 202 |
|---|
| Market Cap: | 948.01B |
|---|
| P/E (ttm): | 63.98 |
|---|
| EPS (ttm): | 2.09 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
Quotes delayed, except where indicated otherwise. Currency in ARS.
Headlines
- Dow's recovery is old news to these top fundsAP(Thu, Mar 7)
- News Summary: Pfizer painkiller patent extendedAP(Tue, Mar 5)
- How the Dow 30 have performed since Oct. 9, 2007AP(Tue, Mar 5)
- Pfizer painkiller gets longer patent protectionAP(Tue, Mar 5)
- Ranbaxy Labs says it will sell generic PristiqAP(Tue, Mar 5)
- Acura Pharma jumps on Nexafed pharmacy dealAP(Tue, Mar 5)
- Mylan rises on purchase of injectable drug makerAP(Thu, Feb 28)
- Optimer board to review strategic alternativesAP(Wed, Feb 27)
- FDA expands approval of Bayer cancer drugAP(Mon, Feb 25)
- SciClone restating results, cites revenue errorsAP(Fri, Feb 22)
- Drugmaker Actavis' 4Q earnings sink 70 percentAP(Tue, Feb 19)
- Nestle makes $11.55 billion profit in 2012AP(Thu, Feb 14)
- Agilent forms diagnostic partnership with PfizerAP(Tue, Feb 12)
- Mylan names 2 to board, including co. presidentAP(Mon, Feb 11)
- Teva Pharmaceutical 4Q profit falls 37 percentAP(Thu, Feb 7)
Reports
- No Reports available for PFE.BA at this time.
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 16.46 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
()
: | N/A |
|---|
| Quarterly EPS Est
()
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells medicines for people and animals worldwide. Its Primary Care segment offers human prescription pharmaceutical products primarily prescribed by primary-care phys...
View More